Randomised Investigation of OPC 34712 in subjects with Alzheimers

• Research type

  Research Study

• Full title

  A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Flexible Dosing of Brexpiprazole (OPC-34712) in the Treatment of Subjects with Agitation Associated with Dementia of the Alzheimer’s Type

• IRAS ID

  152454

• Contact name

  Louris Elias

• Contact email

  lucy.elias@kmpt.nhs.uk

• Sponsor organisation

  Otsuka Pharmaceutical Development & Commercialization, Inc.

• Eudract number

  2013-000503-17

• ISRCTN Number

  n/a

• REC name

  East of England - Essex Research Ethics Committee

• REC reference

  14/EE/0195

• Date of REC Opinion

  11 Jun 2014

• REC opinion

  Unfavourable Opinion